Mid-Year Report
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Income
—
Expenses
$580,000
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part B coverage issues Section 1861 (t)(2)(B) Social Security Act H.R. 3162, Children's Health and Medicare Protection Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING | N/A |
Copyright/Patent/Trademark CPT
HR 2795 Patent Reform Act of 2005
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING | N/A |
Medical/Disease Research/Clinical Labs MED
PDUFA-IV Biologics FDA Appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING | N/A |
Budget/Appropriations BUD
H. Con. Res. 99, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, Medicare/Medicaid, drug importation, and comparative effectiveness provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.